QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Résumé Extracto Full Text PDF For Our Patients Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Articles Ahead of Print [Order Reprint] Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vivian, E. M Articles by Gutierrez, A. M Search for Related Content PubMed PubMed Citation Articles by Vivian, E. M Articles by Gutierrez, A. M

DIABETES

Insulin Strategies for Type 2 Diabetes Mellitus

Associate Professor of Clinical Pharmacy, College of Pharmacy, Western University of Health Sciences, Pomona, CA

Sophia V Olarte, PharmD

at time of writing, Student, College of Pharmacy, Western University of Health Sciences; now, Staff Pharmacist, Redlands Community Hospital, Redlands, CA

Ann M Gutierrez, PharmD

at time of writing, Student, College of Pharmacy, Western University of Health Sciences; now, Primary Care Resident, Veterans Affairs Greater Los Angeles Healthcare System, North Hills, CA

Reprints: Eva M Vivian PharmD BCPS CDE BC-ADM, College of Pharmacy, Western University of Health Sciences, 309 E. Second St., Pomona, CA 91766-1854, fax 909/469-5539, evivian{at}westernu.edu

OBJECTIVE: To review the currently available insulin analogs and the benefits of insulin therapy in the treatment of type 2 diabetes mellitus.

DATA SOURCES: A MEDLINE search (1990–March 2004) was conducted using insulin and type 2 diabetes mellitus as search terms to identify clinical trials and review articles. The bibliographies of identified articles were reviewed.

STUDY SELECTION AND DATA EXTRACTION: All articles identified from the data sources were evaluated and deemed relevant if they included and assessed clinical outcomes.

DATA SYNTHESIS: Since its discovery in 1922, insulin therapy has been the only available pharmacologic treatment for type 1 diabetes and a mainstay therapy for patients with type 2 diabetes who fail to obtain glycemic control with oral antidiabetic agents. This article reviews the current insulin analogs available on the market and insulin regimens that are designed to mimic the pancreatic ß-cells' response to a glucose load.

CONCLUSIONS: Insulin therapy is often withheld until late in the disease process for patients with type 2 diabetes mellitus. This results in an enormous burden of disease for patients. Insulin therapy is beneficial in obtaining glycemic control and may attenuate the complications associated with diabetes.

Key Words: insulin, type 2 diabetes mellitus

Published Online, October 12, 2004. www.theannals.com, DOI 10.1345/aph.1D635

THIS ARTICLE IS APPROVED FOR CONTINUING EDUCATION CREDIT
ACPE UNIVERSAL PROGRAM NUMBER: 407-000-04-034-H01

This article has been cited by other articles:

				J. A Davidson Comment: insulin strategies for type 2 diabetes mellitus Ann. Pharmacother., May 1, 2005; 39(5): 975 - 976. [Full Text] [PDF]

				E. M Vivian Comment: insulin strategies for type 2 diabetes mellitus: Author's Reply Ann. Pharmacother., May 1, 2005; 39(5): 976 - 976. [Full Text] [PDF]